Effects of Combined Angiopoietin-1 and Vascular Endothelial Growth Factor Gene Transfer on Neovascular Permeability of Rat Hindlimb Ischemia
祖凌云,蒋捷,姜宁,陈莉,郭艳红,李黔,高炜
DOI: https://doi.org/10.3969/j.issn.1004-8812.2004.02.013
2004-01-01
Abstract:Objective To investigate the effect of combined gene transfer of Angiopoietin 1 (Ang 1) gene and Vascular Endothelial Growth Factor (VEGF) gene, with different proportions, on neovascular permeability in a rat model of hindlimb ischemia Methods Naked plasmid DNA encoding VEGF (pcD 2/VEGF) and Ang 1 (pcD 2/Ang 1) were delivered either alone or in combination into the rat ischemic skeletal muscle by intramuscular electroporation Different proportions of the two genes in the combination were investigated RT PCR and immunohistochemistry were used to detect gene expression The permeability of the neovasculature was evaluated by the skeletal muscle Evans blue uptake assay Results High levels of VEGF and Ang 1 mRNA and protein expression were detected Quantification of the leakage levels of Evans blue dye demonstrated that the increase of the amount of pcD 2/VEGF from 100 μg, 200 μg to 400 μg resulted in a gradual increase in the vascular permeability, whereas the vasculas permeability was decreased with the increase of the amount of pcD 2/Ang 1 Evans blue uptake in group of pcD 2/VEGF 100 μg + pcD 2/Ang 1?200 μg was the closest to that of the normal group (8 57±0 74 ng/ml vs 8 42±0 82 ng/ml, P 0 05) Conclusion Intramuscular electroporation of pcD 2/Ang 1 can ameliorate the vessel leakage caused by pcD 2/VEGF and thus may represent a feasible and safe therapeutic strategy for patients with tissue ischemia
What problem does this paper attempt to address?